The EGAPP initiative: Lessons learned

Ned Calonge, Roger D. Klein, Alfred O. Berg, Jonathan S. Berg, Katrina Armstrong, Jeffrey Botkin, Doug Campos-Outcalt, Benjamin Djulbegovic, Nancy L. Fisher, Theodore G. Ganiats, James E. Haddow, Maxine Hayes, A. Cecile J W Janssens, Celia Kaye, Donald O. Lyman, Kenneth Offit, Stephen G. Pauker, Kathryn A. Phillips, Margaret Piper, Carolyn (Sue) RichardsJoan A. Scott, Ora L. Strickland, Steven Teutsch, Sean R. Tunis, David L. Veenstra, Marc S. Williams, Doris T. Zallen

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

The Evaluation of Genomic Applications in Practice and Prevention Working Group was first convened in 2005 to develop and test evidence-based methods for the evaluation of genomic tests in transition from research to clinical and public health practice. Over the ensuing years, the Working Group has met 26 times, publishing eight recommendation statements, two methods papers, and one outcomes paper, as well as planning and serving as technical experts on numerous associated systematic reviews. Evaluation of Genomic Applications in Practice and Prevention methods have evolved to address implications of the proliferation of genome-wide association studies and are currently expanding to face challenges expected from clinical implementation of whole-genome sequencing tests. In this article, we review the work of the Evaluation of Genomic Applications in Practice and Prevention Working Group over the first 8 years of its existence with an emphasis on lessons learned throughout the process. It is hoped that in addition to the published methods of the Working Group, the lessons we have learned along the way will be informative to others who are producers and consumers of evidence-based guidelines in the field of genomic medicine.

Original languageEnglish (US)
Pages (from-to)217-224
Number of pages8
JournalGenetics in Medicine
Volume16
Issue number3
DOIs
StatePublished - 2014

Fingerprint

Public Health Practice
Genome-Wide Association Study
Medicine
Genome
Guidelines
Research

Keywords

  • Evidence-based medicine
  • Genetics
  • Guideline development
  • Public health genomics
  • Systematic review methods

ASJC Scopus subject areas

  • Genetics(clinical)
  • Medicine(all)

Cite this

Calonge, N., Klein, R. D., Berg, A. O., Berg, J. S., Armstrong, K., Botkin, J., ... Zallen, D. T. (2014). The EGAPP initiative: Lessons learned. Genetics in Medicine, 16(3), 217-224. https://doi.org/10.1038/gim.2013.110

The EGAPP initiative : Lessons learned. / Calonge, Ned; Klein, Roger D.; Berg, Alfred O.; Berg, Jonathan S.; Armstrong, Katrina; Botkin, Jeffrey; Campos-Outcalt, Doug; Djulbegovic, Benjamin; Fisher, Nancy L.; Ganiats, Theodore G.; Haddow, James E.; Hayes, Maxine; Janssens, A. Cecile J W; Kaye, Celia; Lyman, Donald O.; Offit, Kenneth; Pauker, Stephen G.; Phillips, Kathryn A.; Piper, Margaret; Richards, Carolyn (Sue); Scott, Joan A.; Strickland, Ora L.; Teutsch, Steven; Tunis, Sean R.; Veenstra, David L.; Williams, Marc S.; Zallen, Doris T.

In: Genetics in Medicine, Vol. 16, No. 3, 2014, p. 217-224.

Research output: Contribution to journalArticle

Calonge, N, Klein, RD, Berg, AO, Berg, JS, Armstrong, K, Botkin, J, Campos-Outcalt, D, Djulbegovic, B, Fisher, NL, Ganiats, TG, Haddow, JE, Hayes, M, Janssens, ACJW, Kaye, C, Lyman, DO, Offit, K, Pauker, SG, Phillips, KA, Piper, M, Richards, CS, Scott, JA, Strickland, OL, Teutsch, S, Tunis, SR, Veenstra, DL, Williams, MS & Zallen, DT 2014, 'The EGAPP initiative: Lessons learned', Genetics in Medicine, vol. 16, no. 3, pp. 217-224. https://doi.org/10.1038/gim.2013.110
Calonge N, Klein RD, Berg AO, Berg JS, Armstrong K, Botkin J et al. The EGAPP initiative: Lessons learned. Genetics in Medicine. 2014;16(3):217-224. https://doi.org/10.1038/gim.2013.110
Calonge, Ned ; Klein, Roger D. ; Berg, Alfred O. ; Berg, Jonathan S. ; Armstrong, Katrina ; Botkin, Jeffrey ; Campos-Outcalt, Doug ; Djulbegovic, Benjamin ; Fisher, Nancy L. ; Ganiats, Theodore G. ; Haddow, James E. ; Hayes, Maxine ; Janssens, A. Cecile J W ; Kaye, Celia ; Lyman, Donald O. ; Offit, Kenneth ; Pauker, Stephen G. ; Phillips, Kathryn A. ; Piper, Margaret ; Richards, Carolyn (Sue) ; Scott, Joan A. ; Strickland, Ora L. ; Teutsch, Steven ; Tunis, Sean R. ; Veenstra, David L. ; Williams, Marc S. ; Zallen, Doris T. / The EGAPP initiative : Lessons learned. In: Genetics in Medicine. 2014 ; Vol. 16, No. 3. pp. 217-224.
@article{8d804b6d08ff4cc688466871096cf7a0,
title = "The EGAPP initiative: Lessons learned",
abstract = "The Evaluation of Genomic Applications in Practice and Prevention Working Group was first convened in 2005 to develop and test evidence-based methods for the evaluation of genomic tests in transition from research to clinical and public health practice. Over the ensuing years, the Working Group has met 26 times, publishing eight recommendation statements, two methods papers, and one outcomes paper, as well as planning and serving as technical experts on numerous associated systematic reviews. Evaluation of Genomic Applications in Practice and Prevention methods have evolved to address implications of the proliferation of genome-wide association studies and are currently expanding to face challenges expected from clinical implementation of whole-genome sequencing tests. In this article, we review the work of the Evaluation of Genomic Applications in Practice and Prevention Working Group over the first 8 years of its existence with an emphasis on lessons learned throughout the process. It is hoped that in addition to the published methods of the Working Group, the lessons we have learned along the way will be informative to others who are producers and consumers of evidence-based guidelines in the field of genomic medicine.",
keywords = "Evidence-based medicine, Genetics, Guideline development, Public health genomics, Systematic review methods",
author = "Ned Calonge and Klein, {Roger D.} and Berg, {Alfred O.} and Berg, {Jonathan S.} and Katrina Armstrong and Jeffrey Botkin and Doug Campos-Outcalt and Benjamin Djulbegovic and Fisher, {Nancy L.} and Ganiats, {Theodore G.} and Haddow, {James E.} and Maxine Hayes and Janssens, {A. Cecile J W} and Celia Kaye and Lyman, {Donald O.} and Kenneth Offit and Pauker, {Stephen G.} and Phillips, {Kathryn A.} and Margaret Piper and Richards, {Carolyn (Sue)} and Scott, {Joan A.} and Strickland, {Ora L.} and Steven Teutsch and Tunis, {Sean R.} and Veenstra, {David L.} and Williams, {Marc S.} and Zallen, {Doris T.}",
year = "2014",
doi = "10.1038/gim.2013.110",
language = "English (US)",
volume = "16",
pages = "217--224",
journal = "Genetics in Medicine",
issn = "1098-3600",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - The EGAPP initiative

T2 - Lessons learned

AU - Calonge, Ned

AU - Klein, Roger D.

AU - Berg, Alfred O.

AU - Berg, Jonathan S.

AU - Armstrong, Katrina

AU - Botkin, Jeffrey

AU - Campos-Outcalt, Doug

AU - Djulbegovic, Benjamin

AU - Fisher, Nancy L.

AU - Ganiats, Theodore G.

AU - Haddow, James E.

AU - Hayes, Maxine

AU - Janssens, A. Cecile J W

AU - Kaye, Celia

AU - Lyman, Donald O.

AU - Offit, Kenneth

AU - Pauker, Stephen G.

AU - Phillips, Kathryn A.

AU - Piper, Margaret

AU - Richards, Carolyn (Sue)

AU - Scott, Joan A.

AU - Strickland, Ora L.

AU - Teutsch, Steven

AU - Tunis, Sean R.

AU - Veenstra, David L.

AU - Williams, Marc S.

AU - Zallen, Doris T.

PY - 2014

Y1 - 2014

N2 - The Evaluation of Genomic Applications in Practice and Prevention Working Group was first convened in 2005 to develop and test evidence-based methods for the evaluation of genomic tests in transition from research to clinical and public health practice. Over the ensuing years, the Working Group has met 26 times, publishing eight recommendation statements, two methods papers, and one outcomes paper, as well as planning and serving as technical experts on numerous associated systematic reviews. Evaluation of Genomic Applications in Practice and Prevention methods have evolved to address implications of the proliferation of genome-wide association studies and are currently expanding to face challenges expected from clinical implementation of whole-genome sequencing tests. In this article, we review the work of the Evaluation of Genomic Applications in Practice and Prevention Working Group over the first 8 years of its existence with an emphasis on lessons learned throughout the process. It is hoped that in addition to the published methods of the Working Group, the lessons we have learned along the way will be informative to others who are producers and consumers of evidence-based guidelines in the field of genomic medicine.

AB - The Evaluation of Genomic Applications in Practice and Prevention Working Group was first convened in 2005 to develop and test evidence-based methods for the evaluation of genomic tests in transition from research to clinical and public health practice. Over the ensuing years, the Working Group has met 26 times, publishing eight recommendation statements, two methods papers, and one outcomes paper, as well as planning and serving as technical experts on numerous associated systematic reviews. Evaluation of Genomic Applications in Practice and Prevention methods have evolved to address implications of the proliferation of genome-wide association studies and are currently expanding to face challenges expected from clinical implementation of whole-genome sequencing tests. In this article, we review the work of the Evaluation of Genomic Applications in Practice and Prevention Working Group over the first 8 years of its existence with an emphasis on lessons learned throughout the process. It is hoped that in addition to the published methods of the Working Group, the lessons we have learned along the way will be informative to others who are producers and consumers of evidence-based guidelines in the field of genomic medicine.

KW - Evidence-based medicine

KW - Genetics

KW - Guideline development

KW - Public health genomics

KW - Systematic review methods

UR - http://www.scopus.com/inward/record.url?scp=84895813688&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84895813688&partnerID=8YFLogxK

U2 - 10.1038/gim.2013.110

DO - 10.1038/gim.2013.110

M3 - Article

C2 - 23928914

AN - SCOPUS:84895813688

VL - 16

SP - 217

EP - 224

JO - Genetics in Medicine

JF - Genetics in Medicine

SN - 1098-3600

IS - 3

ER -